Replies to post #232885 on Biotech Values

[xavierprivas]

This is laughable compared to AUPH p3 result as an example.
https://ir.auriniapharma.com/presentations

and click on NKF 2020 Spring Clinical Meetings: AURORA Phase 3 Results
and patients were able to achieve UPCR <=.5mg at 52 weeks.

Not a recommendation to buy AUPH. My memory is hazy as I don't know
much about LN, but Velcade is better I think.